M

Medicinova
D

MNOV

1.35000
USD
-0.01
(-0.74%)
مغلق
حجم التداول
0
الربح لكل سهم
-1
العائد الربحي
-
P/E
-6
حجم السوق
66,212,432
أصول ذات صلة
C
CRSP
0.050
(0.12%)
41.360 USD
E
EDIT
-0.20500
(-9.45%)
1.96500 USD
N
NTLA
-0.04000
(-0.48%)
8.31000 USD
Q
QURE
-0.650
(-4.07%)
15.340 USD
R
RARE
-1.820
(-4.63%)
37.490 USD
S
SGMO
-0.02290
(-4.55%)
0.48010 USD
S
SRPT
-1.080
(-2.90%)
36.170 USD
المزيد
الأخبار المقالات

العنوان: Medicinova

القطاع: Healthcare
الصناعة: Biotechnology
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.